Native valve endocarditis due to coagulase-negative staphylococci. Clinical and microbiologic features.

G. Caputo,G. Archer,S. Calderwood,M. Dinubile,A. Karchmer

DOI: https://doi.org/10.1016/0002-9343(87)90889-8

1987-10-01

Abstract:

What problem does this paper attempt to address?

Mycobacterium avium complex (MAC) infection in severely immunocompromised people living with HIV: Findings from a five-year cohort

María del Rocío Fernández-Díaz,Naya Faro-Miguez,María Aguilera-Franco,Leopoldo Muñoz-Medina,Andrés Ruiz-Sancho,Javier Rodríguez-Granger,Emilio Guirao-Arrabal

DOI: https://doi.org/10.1177/09564624241297835

2024-11-07

International Journal of STD & AIDS

Abstract:International Journal of STD &AIDS, Ahead of Print. BackgroundWe sought to clarify the current incidence, risk factors and symptoms of disseminated Mycobacterium avium complex (dMAC) infection in admitted people living with HIV in a hospital in the Southeast of Spain.Methods5-years observational, retrospective and single-centre study. Demographic, clinical and analytical variables, along with microbiological, treatment and follow-up were collected.ResultsFive cases of dMAC infection in severely immunocompromised people living with HIV people living were found. dMAC was diagnosed in 22.7% of patients under 100 CD4. All patients presented with fever and clinical manifestations of pneumonia, lymphadenopathy, or gastrointestinal symptoms. Despite low CD4 levels and high viral loads in some cases, primary prophylaxis had not been previously administered.ConclusionsUntil 2018, U.S. American guidelines recommended antimycobacterial prophylaxis for patients with low CD4 cell counts, a practice not adopted in Europe. Untreated dMAC infection is associated with high morbidity and mortality rates. dMAC infection represents a prevalent disease in severely immunosuppressed people living with HIV. dMAC requires a high index of suspicion in this population, in order to perform mycobacterial cultures from different samples.

immunology,infectious diseases
Delirium and confusional states.

J. Sturmberg,Jodi Death

2000-11-01

Abstract:
Preliminary Observations of Veterans Without HIV Who Have Mycobacterium avium Complex Pulmonary Disease

Christen L Vagts,Israel Rubinstein

DOI: https://doi.org/10.12788/fp.0230

Abstract:Background: Nontuberculous Mycobacterium-related pulmonary disease (NTM-PD) is commonly caused by Mycobacterium avium complex (MAC) and is increasingly recognized in veterans. NTM-PD carries an increased risk of mortality, and lack of treatment is an predictor of increased mortality. Methods: We describe the clinical characteristics of veterans diagnosed with MAC-pulmonary disease (MAC-PD) followed in a health care setting with varying treatment practices. We reviewed the electronic health records of veterans without HIV who had sputum culture-positive MAC-PD followed at the Jesse Brown Veteran Affairs Medical Center in Chicago, Illinois. Results: We identified 19 veterans diagnosed with MAC-PD between 2008 and 2019. They were predominantly male (89.5%), Black (73.6%), and had a median age of 74 years. Sixteen veterans (84.2%) had underlying lung disease, and 16 (84.2%) were current or former smokers. Respiratory symptoms were reported in 17 veterans (89.5%). Guideline-directed combination antimycobacterial therapy was initiated in 10 veterans (52.6%); however, only 5 (50.0%) completed treatment. Comorbidities, symptoms, and findings on chest imaging at diagnosis were similar among treated and untreated veterans. Conclusions: Clinical, imaging, and treatment attributes of MAC-PD in veterans without HIV who reside in metropolitan Chicago are heterogeneous and are associated with a relatively high mortality rate. Further studies are warranted to characterize MAC-PD and its treatment in veterans without HIV who reside in underresourced urban communities in the US.
How do I manage disseminated Mycobacterium avium complex disease in people with HIV?

Tommaso Matucci,Giacomo Pozza,Angelo Roberto Raccagni,Alberto Borghetti,Silvia Nozza,Andrea Giacomelli,Niccolò Riccardi

DOI: https://doi.org/10.1016/j.cmi.2024.08.022

2024-08-30

Abstract:Background: Advanced HIV disease (AHD) is increasing, with late presentation accounting for half of newly diagnosed people with HIV (PWH) in Europe. Mortality in late-presenting PWH remains high, and Mycobacterium avium complex (MAC) disease, among other opportunistic infections, presents several diagnostic and treatment challenges that lead, ultimately, to a poor clinical outcome. Objectives: We aimed to provide guidance on the diagnosis and treatment of disseminated MAC disease (dMACd) in PWH. Sources: We performed a review of original articles, meta-analyses, and systematic reviews retrieved from PubMed. Content: We reviewed and discussed the most challenging steps in the management of PWH with AHD and dMACd: the current epidemiology in the era of effective antiretroviral treatment; clinical presentation and interpretation of symptoms in the context of other opportunistic infections and immune reconstitution; diagnosis, sampling, and timing to reach a definitive diagnosis; prophylaxis, treatment options, and indications for discontinuing MAC treatment; future perspectives; and the role of rifamycins in the treatment of dMACd. Implications: Despite the widespread availability of effective antiretroviral treatment, dMACd still represents a major cause of morbidity and mortality in PWH with AHD. Residual challenges are mainly related to the difficulties and timing required to reach a definitive diagnosis, and the discussion regarding the role of rifamycins in the treatment of dMACd is still open.
Difficulty in diagnosing intracranial infection caused by Mycobacterium avium in an AIDS patient: case report and review of the literature

Mengyan Wang,Yahui Cui,Jinchuan Shi,Jun Yan

DOI: https://doi.org/10.1186/s13000-024-01515-z

2024-07-09

Abstract:Background: Mycobacterium avium complex (MAC) is an uncommon clinical pathogen, especially in the central nervous system (CNS), and carries a poor prognosis. MAC infections commonly present as immune reconstitution disease (IRD) in HIV patients. Herein, we report a case of intracranial infection caused by MAC in an AIDS patient without disseminated MAC (DMAC) and immune reconstitution inflammatory syndrome (IRIS). Case presentation: A 31-year-old HIV-positive male presented us with progressively worsening CNS symptoms, and neuroimaging revealed ring-enhancing lesions. The intracranial lesions worsened after the empirical therapy for toxoplasma encephalitis and fungal infection. Due to the rapid progression of the disease, the patient died. Mycobacterium avium was the only pathogen in brain tissue after cultures and molecular biology tests. Conclusion: MAC infection in CNS is challenging to diagnose in HIV patients. Our findings emphasize that obtaining tissue samples and applying molecular biology methods is essential to help diagnose the patient as soon as possible to receive adequate treatment.
S3563 A Unique Case of Disseminated Mycobacterium Avium Complex (MAC) Infection in a 34-Year-Old HIV-Positive Patient

Sushreyta Rose,Iqra Kazi,Alexis Maximos

DOI: https://doi.org/10.14309/01.ajg.0001043620.51934.7e

2024-10-26

The American Journal of Gastroenterology

Abstract:Disseminated mycobacterium avium complex (MAC) infection is a significant cause of morbidity and mortality in HIV-positive individuals. We present a case of a 34-year-old HIV-positive patient, leading to the diagnosis of disseminated MAC infection despite initially normal endoscopic findings.

gastroenterology & hepatology
Assays for Assessing Mycobacterium avium Immunity and Evaluating the Effects of Therapeutics

Getahun Abate,Krystal A. Meza,Chase G. Colbert,Christopher S. Eickhoff

DOI: https://doi.org/10.3390/pathogens13100903

IF: 3.7

2024-10-16

Pathogens

Abstract:In Europe and North America, the prevalence of pulmonary nontuberculous mycobacteria (NTM) is increasing. Most pulmonary NTM infections are caused by the Mycobacterium avium complex (MAC). Sadly, the treatment of pulmonary MAC is suboptimal with failure rates ranging from 37% to 58%. Therefore, there is a need to develop new therapeutics. Developing new immunotherapies and studying their interaction with standard or new drugs requires reliable assays. Four different assays including CFSE-based flow cytometry, in vitro protection assays, IFN-γ ELISPOT, and murine infection models were optimized using a reference strain of MAC (ATCC 700898) to help with the development of immunotherapies for MAC. Expansion of proliferating and IFN-γ producing human T cells is optimal after 7 days of stimulation with MAC at a multiplicity of infection (MOI) of 0.1, achieving a stimulation index of 26.5 ± 11.6 (mean ± SE). The in vitro protection assay for MAC works best by co-culturing T cells expanded for 7 days with MAC (MOI 1)-infected autologous macrophages. Aerosol MAC infection of mice allows measurement of the effects of the BCG vaccine and clarithromycin. IFN-γ ELISPOT assays with live MAC (MOI 3) stimulation of splenocytes from mice immunized with BCG help identify differences between unimmunized mice and mice immunized with BCG. In conclusion, multiple assays are available for use to identify MAC-specific effector T cells, which will help in the development of new therapeutics or vaccines against pulmonary MAC.

microbiology
[Treatment with clarithromycin of 173 HIV+ patients with disseminated Mycobacterium avium intracellulare infection]

B Dautzenberg,T Saint-Marc,J Durant,J Reynes,M C Meyohas,M F Legrand,C Truffot,J P Chauvin

Abstract:No treatment was established for disseminated M. avium intracellulare (MAC) infection, a common disease of end stage of AIDS. An open study was conducted to assess in 173 AIDS patients, the activity of clarithromycin. Initial bacteriologic eradication from blood was observed in 136/147 evaluable patients (93%). Acquired resistance to clarithromycin associated with relapse appeared to develop after 2 to 7 months of drug treatment in 31/136 patients with initial success. Early bacteriological relapse was associated with clinical deterioration. Side effects of drug treatment were elevated liver enzymes (26%) and impaired hearing (4%). Side effects conducted to stop treatment in 14 cases (8%) to modified treatment in 8 cases (5%). Our study gave new argues for activity of clarithromycin in disseminated MAC infection.
Role of fluorescence in situ hybridization in detecting mycobacterium avium complex presenting as fever in treatment failure HIV

Vikas Prabhu,Steffi Coelho,Basavaprabhu Achappa,Shrikala Baliga,Leesha Sharon,Jyotsna Shah

DOI: https://doi.org/10.1016/j.jctube.2020.100188

2020-09-10

Abstract:A 49-year-old male HIV positive patient on treatment failure presented with complaints of fever and dysphagia of three weeks duration and later on developed cervical lymphadenopathy along with severe vomiting and abdominal pain. Liver function tests were found to be worsening with severe drop in CD4 counts. An extensive workup for pyrexia was done. FNAC and biopsy of lymph node showed features suggestive of granulomatous lymphadenitis. CBNAAT of the lymph node aspirate was negative for MTB. Blood culture and lymph node cultures were negative for Mycobacterium Avium Complex (MAC). MAC was however, finally detected and reported positive on Fluorescence in Situ Hybridization (FISH) of the cervical lymph node aspirate. Prompt treatment for MAC was initiated with Ethambutol 800 mg OD and Azithromycin 500 mg OD following which fever spikes subsided and lymph node resolved. The Patient's condition gradually improved and was discharged shortly with a good recovery on subsequent follow ups. Fever is one of the common symptoms in patients with MAC infection. Some other clinical manifestations include weight loss, hepatosplenomegaly and intra-abdominal lymphadenopathy. Diagnostic evaluation should be aggressive. As there is a high risk for MAC infection in advanced HIV cases with poor HAART compliance, FISH can be a valuable and effective diagnostic tool in early detection and treatment of MAC.
Unified Current-Source Control for Low-Power Current-Mode-Logic Bit-Serial Circuits

Shogo Kisara,M. Kameyama

DOI: https://doi.org/10.1109/ISMVL.2012.55

2012-05-14

Abstract:This paper presents a low-power multiple-valued VLSI based on two current-source control techniques. The first technique is a current-source control based on valid data signal detection. The other technique is a current-source control such that current sources are turned off within a clock cycle after a logic operation completion signal is detected. In a multiple-valued reconfigurable VLSI, power consumption of a cell with the low-power technique is reduced to 49% in comparison with that of the cell without the low-power technique, when the operating frequency is 500MHz, and the utilization ratio of the cell is 25%.
Diagnosis of mycobacterium avium complex infection utilizing metagenomics next-generation sequencing: a case report

Hongli Li,Luqing Wei,Fenge Li

DOI: https://doi.org/10.3389/fmed.2023.1247034

IF: 3.9

2023-10-18

Frontiers in Medicine

Abstract:Mycobacterium avium-intracellulare complex (MAC) is a type of nontuberculous mycobacteria (NTM) and is associated with underlying pulmonary diseases, such as chronic obstructive pulmonary disease, bronchiectasis, chronic aspiration or recurrent pneumonia, inactive or active tuberculosis, pneumoconiosis, and bronchogenic carcinoma. The risk factors for NTM-PD include host, drug, and environmental factors. In this report, we present the case of a 61-year-old man who developed bilateral lung nodules and was experiencing severe hemoptysis. The repeat acid-fast bacilli test performed on both sputum and bronchoalveolar lavage fluid (BALF) samples showed a negative result, as did the GeneXpert test. We employed metagenomic next-generation sequencing (mNGS) to analyze the lung nodule and BALF samples collected from the patient. Both samples tested positive for MAC within 3 days. In addition, traditional MAC culture, conducted for 2 months, confirmed the growth of MAC in the patient’s BALF. Then, the patient was treated accordingly. Following treatment, a high-resolution chest computed tomography scan revealed a significant reduction in lung nodules of the patient after 2 months. These results indicate that MAC-associated lung nodules were responsible for the patient’s symptoms, emphasizing the need for vigilance in diagnosing MAC infection in the patient without predisposing conditions. Furthermore, these results highlight the potential utility of mNGS as a promising rapid diagnostic tool for MAC infection and its potential role in the diagnosis of NTM disease.

medicine, general & internal
Clinical outcomes of lung transplant recipients with pre‐transplant Mycobacterium avium complex infection

Sonya M. Kothadia,Eric E. Cober,Christine E. Koval,Jem M. Golbin,Susan Harrington,Cyndee Miranda,Lauryn A. Benninger,Jona M. Banzon

DOI: https://doi.org/10.1111/tid.14361

2024-08-28

Transplant Infectious Disease

Abstract:This single‐center retrospective review suggests pre‐transplant Mycobacterium avium complex (MAC) infection in bilateral lung transplant recipients may not uniformly warrant pre‐ or post‐transplant treatment to prevent MAC pulmonary disease post‐transplant, especially in those who are acid‐fast bacillus smear‐negative. Background Lung transplant recipients (LTRs) are at risk for Mycobacterium avium complex (MAC) infections, in part due to the presence of structural lung disease pre‐transplant and relatively higher levels of immunosuppression post‐transplant. There is a lack of data regarding outcomes of LTR with MAC infections pre‐transplant. Methods This is a single‐center retrospective analysis of patients who received lung transplants (LTs) from 2013 to 2020 with 1) evidence of MAC on culture or polymerase chain reaction before or at the time of transplant or 2) granulomas on explant pathology and positive acid‐fast bacillus stains with no other mycobacteria identified. Patients were deemed to have MAC pulmonary disease (MAC‐PD) if they met the American Thoracic Society/Infectious Disease Society of America criteria. Results Fourteen patients (14/882, 2%) met inclusion criteria. Seven patients (7/14, 50%) had pre‐transplant MAC‐PD, four of whom had cavitary disease. None of the 14 patients had smear‐positive cultures at the time of transplant. Two patients in our cohort received treatment for MAC before transplant. Thirteen patients were bilateral LTR (13/14, 93%). One single LTR was the sole patient to receive MAC treatment post‐transplant. No patients developed MAC‐PD after transplant. Conclusion The bilateral LTR in our cohort did not develop MAC‐PD despite not receiving MAC treatment post‐transplant. It is possible source control was achieved with native lung explantation. Our observations suggest patients may not uniformly require pre‐ or post‐transplant MAC treatment if they are smear‐negative and undergo bilateral LT.

immunology,infectious diseases,transplantation
Erratum to "Knowledge discovery and knowledge validation in intensive care"

K. Morik,M. Imhoff,Peter Brockhausen,T. Joachims,U. Gather

DOI: https://doi.org/10.1016/S0933-3657(00)00068-3

2000-10-01

Abstract:
A Theoretical Foundation for the Stein-Winter "Probability Hypothesis Density (PHD)" Multitarget Tracking Approach

R. Mahler

2000-06-20

Abstract:Abstract : In several unpublished manuscripts written from 1993 to 1995, Michael Stein, C.L. Winter, and Robert Tenney introduced a multitarget tracking and evidential-accumulation concept called a "Probability Hypothesis Surface" (PHS). A PHS is the graph of a probability distribution-the Probability Hypothesis Density (PHD)-that, when integrated over a region in target state space, gives the expected number of targets in that region. The PHD is uniquely defined by this property: Any other density function that satisfies it must be the PHD.
The Role of Collaborations in the Sapphire Scientific Data Mining Project

C. Kamath

Abstract:s from the Joint Conference of the Classification Society of
The inhibition by colchicine of the initiation of DNA synthesis by hepatocytes in regenerating rat liver and by cultivated WI‐38 and C3H10T 1/2 cells

Roy Walker,A. Boynton,J. Whitfield

DOI: https://doi.org/10.1002/jcp.1040930112

1977-10-01

Journal of Cellular Physiology

Abstract:Colchicine inhibited the initiation of DNA synthesis by hepatocytes in vivo and by WI‐38 and C3H10T 1/2 cells in vitro. All three cell types were most sensitive to colchicine when it was administered at the time of, or shortly after, proliferative activation (by partial hepatectomy or medium‐serum change). WI‐38 and C3H10T 1/2 cells became less sensitive to colchincine as the time between proliferative activation and addition of the drug was increased. Hepatocytes, on the other hand, showed a second stage of sensitivity immediately before the onset of DNA synthesis. Ongoing DNA synthesis was not inhibited by colchicine in any of the cell types. The two prereplicative stages of colchicine sensitivity in liver were also sensitive to vincristine but not to lumicolchicine, an analogue of colchicine which does not bind to tubulin. The data obtained with these drugs indicates that microtubules may be involved in the prereplicative stages of cell proliferation, but non‐specific binding to other membrane proteins cannot be ruled out. Colchicine (at a dose of 50 μg/100 g of body weight), which when injected 30 minutes after hepatectomy delayed the initiation of DNA synthesis for at least 14 hours, delayed the induction of ornithine decarboxylase (at the beginning of prereplicative development) by only two hours. Thus, the inhibitory action of colchicine on the initiation of DNA synthesis does not appear to be mediated by inhibition of polyamine synthesis.
Electrostatically actuated resonant microcantilever beam in CMOS technology for the detection of chemical weapons

I. Voiculescu,M. Zaghloul,R. McGill,E. Houser,G. Fedder

DOI: https://doi.org/10.1109/JSEN.2005.851016

IF: 4.3

2005-07-18

IEEE Sensors Journal

Abstract:The design, fabrication, and testing of a resonant cantilever beam in complementary metal-oxide semiconductor (CMOS) technology is presented in this paper. The resonant cantilever beam is a gas-sensing device capable of monitoring hazardous vapors and gases at trace concentrations. The new design of the cantilever beam described here includes interdigitated fingers for electrostatic actuation and a piezoresistive Wheatstone bridge design to read out the deflection signal. The reference resistors of the Wheatstone bridge are fabricated on auxiliary beams that are immediately adjacent to the actuated device. The whole device is fabricated using a 0.6-/spl mu/m, three-metal, double-poly CMOS process, combined with subsequent micromachining steps. A custom polymer layer is applied to the surface of the microcantilever beam to enhance its sorptivity to a chemical nerve agent. Exposing the sensor with the nerve agent simulant dimethylmethylphosphonate (DMMP), provided a demonstrated detection at a concentration of 20 ppb or 0.1 mg/m/sup 3/. These initial promising results were attained with a relatively simple design, fabricated in standard CMOS, which could offer an inexpensive option for mass production of a miniature chemical detector, which contains on chip electronics integrated to the cantilever beam.
Multiple bacterial culture positivity reflects the severity and prognosis as bronchiectasis in Mycobacterium avium complex pulmonary disease

Masashi Ito,Koji Furuuchi,Keiji Fujiwara,Fumiya Watanabe,Tatsuya Kodama,Fumiko Uesugi,Yoshiaki Tanaka,Takashi Yoshiyama,Atsuyuki Kurashima,Ken Ohta,Kozo Morimoto

DOI: https://doi.org/10.1016/j.rmed.2023.107417

Abstract:Background: Bacterial coinfections are observed in 19-66% of patients with Mycobacterium avium complex pulmonary disease (MAC-PD) during the entire duration of the disease. The impact of bacterial coinfection at diagnosis on the clinical course of MAC-PD has not been reported. Methods: Among 558 patients diagnosed with MAC-PD between January 2016 and December 2020, 218 patients who underwent sputum culture tests twice or more within one year before and after diagnosis were included. We compared the patient characteristics and disease courses between the patients who had the same bacterial species detected twice or more (bacterial culture positive group: BCP group) and those who never had bacteria cultured (bacterial culture negative group: BCN group). Results: We included 70 patients in the BCP group and 74 in the BCN group. The radiological findings showed that BCP at diagnosis correlated with a high modified Reiff score. During the median follow-up period of 42 months, the patients in the BCP group were more likely to accomplish spontaneous sputum conversion of MAC. The treatment initiation rate for MAC-PD in the BCP group was lower than that in the BCN group (41.4% vs. 67.6%, P = 0.003). In contrast, the time to the first bronchiectasis exacerbation in the BCP group was shorter than that in the BCN group, and the frequency of bronchiectasis exacerbations was higher in the BCP group. Conclusions: Patients with BCP at diagnosis are less likely to initiate treatment for MAC-PD and more likely to develop bronchiectasis exacerbation.
Mycobacterium avium complex-associated cholecystitis in AIDS patient: a case description and review of literature

Firas El Chaer,Nadine Harris,Hana El Sahly,Vagish Hemmige,Elvia Martinez Blanco,Laila Woc-Colburn

DOI: https://doi.org/10.1177/0956462415588445

2016-09-29

Abstract:AIDS-related cholangiopathy was common in patients with AIDS prior to the advent of highly active antiretroviral therapy. Mycobacterium avium complex (MAC) is the most common opportunistic bacterial infection seen in AIDS patients and one of many opportunistic pathogens implicated in AIDS cholangiopathy. We describe a case of acute cholecystitis secondary to MAC in a patient with likely AIDS cholangiopathy. The patient, a 37-year-old Hispanic woman with CD4 + cell count of 10 cells/mm 3 who was previously diagnosed with disseminated MAC, presented with a eight days of diffuse abdominal pain and anorexia. Radiologic imaging suggested acute cholecystitis, so the patient underwent open cholecystectomy. Pathology staining of the gall bladder wall revealed acid-fast bacilli consistent with MAC. The patient had been receiving appropriate therapy as an outpatient for MAC with presumed reliable adherence, but we suggest her burden of disease was high due to her severe immunosuppressive state. A thorough review of the literature showed that there are many infectious and non-infectious aetiologies for AIDS-associated cholangiopathy. Acute cholecystitis can develop in the setting of AIDS cholangiopathy, potentially secondary to the opportunistic infection that initially caused the cholangiopathy. MAC-related gallbladder disease needs to be considered in patients with advanced AIDS who present with evidence of acute cholecystitis.

immunology,infectious diseases
S4905 From Lymphoma to MAC: Uncovering the True Cause of Chronic Diarrhea in an HIV Patient

Spyridon Peppas,Stephanie M. Woo,Srikar Reddy,Metin Ozdemirli,Thomas M. Loughney

DOI: https://doi.org/10.14309/01.ajg.0001048988.05075.64

2024-10-26

The American Journal of Gastroenterology

Abstract:Diarrhea in patients with human immunodeficiency virus (HIV) infection can stem from various causes, including infections, malignancies, and medications. Despite reduced infectious diarrhea rates with anti-retroviral treatment (ART), non-adherence can lead to advanced HIV with opportunistic infections. Mycobacterium avium complex (MAC) infection can be encountered in patients with advanced HIV and CD4 count < 50 cells/mm 3 . Here, we present a case of chronic diarrhea in an HIV patient initially suspected for lymphoma, ultimately diagnosed with disseminated MAC infection.

gastroenterology & hepatology

Native valve endocarditis due to coagulase-negative staphylococci. Clinical and microbiologic features.

Mycobacterium avium complex (MAC) infection in severely immunocompromised people living with HIV: Findings from a five-year cohort

Delirium and confusional states.

Preliminary Observations of Veterans Without HIV Who Have Mycobacterium avium Complex Pulmonary Disease

How do I manage disseminated Mycobacterium avium complex disease in people with HIV?

Difficulty in diagnosing intracranial infection caused by Mycobacterium avium in an AIDS patient: case report and review of the literature

S3563 A Unique Case of Disseminated Mycobacterium Avium Complex (MAC) Infection in a 34-Year-Old HIV-Positive Patient

Assays for Assessing Mycobacterium avium Immunity and Evaluating the Effects of Therapeutics

[Treatment with clarithromycin of 173 HIV+ patients with disseminated Mycobacterium avium intracellulare infection]

Role of fluorescence in situ hybridization in detecting mycobacterium avium complex presenting as fever in treatment failure HIV

Unified Current-Source Control for Low-Power Current-Mode-Logic Bit-Serial Circuits

Diagnosis of mycobacterium avium complex infection utilizing metagenomics next-generation sequencing: a case report

Clinical outcomes of lung transplant recipients with pre‐transplant Mycobacterium avium complex infection

Erratum to "Knowledge discovery and knowledge validation in intensive care"

A Theoretical Foundation for the Stein-Winter "Probability Hypothesis Density (PHD)" Multitarget Tracking Approach

The Role of Collaborations in the Sapphire Scientific Data Mining Project

The inhibition by colchicine of the initiation of DNA synthesis by hepatocytes in regenerating rat liver and by cultivated WI‐38 and C3H10T 1/2 cells

Electrostatically actuated resonant microcantilever beam in CMOS technology for the detection of chemical weapons

Multiple bacterial culture positivity reflects the severity and prognosis as bronchiectasis in Mycobacterium avium complex pulmonary disease

Mycobacterium avium complex-associated cholecystitis in AIDS patient: a case description and review of literature

S4905 From Lymphoma to MAC: Uncovering the True Cause of Chronic Diarrhea in an HIV Patient